Early Evaluation and the Effect of Socioeconomic Factors on Neurodevelopment in Infants with Tetralogy of Fallot.


Journal

Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 06 09 2020
accepted: 06 12 2020
pubmed: 4 2 2021
medline: 27 5 2021
entrez: 3 2 2021
Statut: ppublish

Résumé

Neurodevelopmental sequelae are prevalent among patients with congenital heart defects (CHD). In a study of infants and children with repaired tetralogy of Fallot (TOF), we sought to identify those at risk for abnormal neurodevelopment and to test associations between socioeconomic and medical factors with neurodevelopment deficits. Single-center retrospective observational study of patients with repaired TOF that were evaluated at the institution's Cardiac Kids Developmental Follow-up Program (CKDP) between 2012 and 2018. Main outcomes included neurodevelopmental test scores from the Bayley Infant Neurodevelopmental Screener (BINS), Peabody Developmental Motor Scale (PDMS), and Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). Mixed effects linear regression and marginal logistic regression models tested relationships between patient characteristics and outcomes. Sub-analyses were conducted to test correlations between initial and later neurodevelopment tests. In total, 49 patients were included, predominantly male (n = 33) and white (n = 28), first evaluated at a median age of 4.5 months. Forty-three percent of patients (n = 16) had deficits in the BINS, the earliest screening test. Several socioeconomic parameters and measures of disease complexity were associated with neurodevelopment, independently of genetic syndrome. Early BINS and PDMS performed in infancy were associated with Bayley-III scores performed after 1 year of age. Early screening identifies TOF patients at risk for abnormal neurodevelopment. Socioeconomic factors and disease complexity are associated with abnormal neurodevelopment and should be taken into account in the risk stratification and follow-up of these patients. Early evaluation with BINS and PDMS is suggested for detection of early deficits.

Identifiants

pubmed: 33533966
doi: 10.1007/s00246-020-02525-6
pii: 10.1007/s00246-020-02525-6
pmc: PMC7990815
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

643-653

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL125521
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES013508
Pays : United States
Organisme : NIH HHS
ID : K01HL125521
Pays : United States

Références

J Am Heart Assoc. 2018 Feb 2;7(3):
pubmed: 29420218
Health Place. 2017 Jan;43:151-157
pubmed: 28061392
J Am Heart Assoc. 2018 Oct 16;7(20):e010342
pubmed: 30371284
Cardiol Young. 2015 Feb;25(2):338-47
pubmed: 24512980
N Engl J Med. 2007 Nov 8;357(19):1928-38
pubmed: 17989385
J Thorac Cardiovasc Surg. 2007 May;133(5):1344-53, 1353.e1-3
pubmed: 17467455
J Thorac Cardiovasc Surg. 2003 Nov;126(5):1385-96
pubmed: 14666010
J Pediatr Psychol. 2001 Jan-Feb;26(1):33-40
pubmed: 11145730
Circulation. 2012 May 1;125(17):2081-91
pubmed: 22456475
Paediatr Child Health. 2018 Apr;23(2):92-95
pubmed: 29686491
J Am Heart Assoc. 2018 May 16;7(11):
pubmed: 29769202
J Dev Behav Pediatr. 1998 Jun;19(3):155-61
pubmed: 9648040
J Am Heart Assoc. 2020 Apr 21;9(8):e015255
pubmed: 32306820
Qual Life Res. 2006 May;15(4):663-73
pubmed: 16688499
Pediatrics. 2015 May;135(5):816-25
pubmed: 25917996
J Thorac Cardiovasc Surg. 2014 Apr;147(4):1312-8
pubmed: 23879933
Circulation. 2010 Jan 5;121(1):26-33
pubmed: 20026783
Pediatrics. 2013 May;131(5):e1502-8
pubmed: 23610203
Circulation. 2012 Aug 28;126(9):1143-72
pubmed: 22851541
Dev Med Child Neurol. 2000 Jan;42(1):25-31
pubmed: 10665972
J Thorac Cardiovasc Surg. 2010 Dec;140(6):1230-7
pubmed: 20951391
Circulation. 2009 Feb 10;119(5):709-16
pubmed: 19171858
Birth Defects Res A Clin Mol Teratol. 2011 Dec;91(12):1011-8
pubmed: 22002854
Psychol Bull. 2000 Mar;126(2):309-37
pubmed: 10748645
J Child Neurol. 2014 Oct;29(10):1349-55
pubmed: 24563478
Cardiol Young. 2007 Apr;17(2):189-95
pubmed: 17338838
Pediatr Cardiol. 2013 Mar;34(3):606-11
pubmed: 22976198
J Pediatr. 2016 Jan;168:220-225.e1
pubmed: 26490132

Auteurs

Emmanuelle Favilla (E)

Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA. favillae@chop.edu.
Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA. favillae@chop.edu.

Jennifer A Faerber (JA)

Department of Biomedical and Health Informatics, Data Science and Biostatistics Unit, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Lyla E Hampton (LE)

Department of Child & Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Vicky Tam (V)

Cartographic Modeling Lab, University of Pennsylvania, Philadelphia, PA, USA.

Grace DeCost (G)

Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Chitra Ravishankar (C)

Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

J William Gaynor (JW)

Division of Cardiothoracic Surgery, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Alisa Burnham (A)

Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Daniel J Licht (DJ)

Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Laura Mercer-Rosa (L)

Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH